Status:
ENROLLING_BY_INVITATION
Comparative Study of Negative-Pressure Wound Therapy Integrated With Silver Nanoparticle Spray Versus Negative-Pressure Wound Therapy in Post-Revascularization Diabetic Foot Wound Management
Lead Sponsor:
Kafrelsheikh University
Conditions:
Ischemia Limb
Diabete Mellitus
Eligibility:
All Genders
40-80 years
Brief Summary
This was a prospective, parallel-group, randomized controlled trial conducted at the Vascular Surgery Department of Kafrelsheikh University Hospital, Egypt. The study was approved by the Institutional...
Eligibility Criteria
Inclusion
- Patient with critical limb ischemia(CLI) Rutherford stage 6 or Fontaine stage 4. Wounds classified as Wagner classification grade 2 to 4.Successful revascularization was confirmed by imaging and clinical assessment.
Exclusion
- \- 1. Patients with active infection(pus discharge and still need debridement), osteomyelitis.
- 2\. patients who are allergic to silver or any components used in NPWT. 3. patients who are unable to follow up with us. patient
Key Trial Info
Start Date :
May 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 10 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07147790
Start Date
May 5 2024
End Date
December 10 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafr El Shaykh University
Kafr ash Shaykh, Kafrelshaykh Governorate, Egypt, 33511